The peptides for weight loss Australia research conversation in 2026 centers on three compounds: retatrutide, a triple-agonist running Phase 3 obesity trials; tesamorelin, a growth-hormone-releasing-hormone analog studied for visceral fat;…
Retatrutide is the most potent weight-management compound in late-stage clinical development. In Australia it can be legally purchased and imported as a research-use-only peptide for in vitro study, but it…
